Hongjie Shen

Case report: CD38-directed CAR-T cell therapy: A novel immunotherapy targeting CD38- positive blasts overcomes TKI and chemotherapy resistance of myeloid chronic myeloid leukemia in blastic phase

Lei Yu, L. Yao, J. Cen, 2022, Frontiers in Immunology.